Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Medtronic
Mallinckrodt
AstraZeneca
McKesson

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Mechanism of Action: Adrenergic alpha-Antagonists

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Drugs with Mechanism of Action: Adrenergic alpha-Antagonists

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia UROXATRAL alfuzosin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021287-001 Jun 12, 2003 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Apnar Pharma Lp TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-002 Mar 30, 1998 AB RX No Yes   Start Trial   Start Trial   Start Trial
Mylan TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075140-004 Feb 11, 2000 AB RX No No   Start Trial   Start Trial   Start Trial
Apnar Pharma Lp TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-003 Mar 30, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
Jubilant Cadista TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075317-001 Dec 20, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Apnar Pharma Lp TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-004 Mar 30, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
Jubilant Cadista TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075317-002 Dec 20, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Colorcon
AstraZeneca
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.